Abstract:Abstract Disclosure: A.T. Coren: None. M.F. Roethle: None. L. Zhang: None. A.Y. Pan: None. S. Jia: None. M.J. Hessner: None. S.M. Cabrera: None. While genetic predisposition for type 1 diabetes (T1D) is strongly conferred by HLA-DR3 and/or HLA-DR4, shifting environmental factors that potentiate β-cell autoimmunity are believed responsible for increasing T1D incidence. Evidence suggests that intestinally mediated exposures, such as the Western diet, influence immunity and T1D risk. Gluten is a potential mediator of inflammation. We have described endogenous innate inflammation in individuals with T1D and their healthy siblings and that T1D progresses when this innate state is augmented by additional inflammatory signals prior to development of protective counter-regulatory mechanisms. We hypothesize that, in genetically susceptible hosts, gluten promotes the innate inflammation that potentiates T1D progression and that its removal will abrogate this risk. In an exploratory pilot study, we enrolled healthy children who had a full sibling with T1D to a 4-wk gluten free diet (GFD). Adherence was measured by self-report and fecal gluten peptide. Pre- and post-GFD plasma was analyzed for changes to microbial antigen detection by TLR4 activation, short chain fatty acids (SCFAs), cytokines, and chemokines. Wilcoxon signed rank tests were used to examine paired data. Stool microbial composition was measured by 16s rRNA bacterial gene sequencing and analyzed by generalized linear mixed models with negative binominal distribution. P<0.05 was considered significant. 28 participants completed the study (mean 13 years, range 2.7-22.1, 20 (71%) females, 22 (79%) non-Hispanic white, 9 (32%) pre-pubertal). 21% had a first degree relative with celiac disease and 11 (39%) had HLA-DR3 and/or DR4. At baseline, 50% had inadequate dietary fiber intake. There was no attrition, but 29% admitted to occasional gluten consumption or had detectable fecal gluten peptides. TLR4 activity trended lower post-GFD (p =0.06). Post-GFD, plasma acetate, an anti-inflammatory SCFA, was increased; hexanoate, an inflammatory fatty acid, was decreased (p<0.001). The plasma-to-fecal ratio of acetate, propionate, butyrate, valerate, and hexanoate were increased. Several inflammatory cytokines/chemokines were significantly reduced post-GFD (IFNα, IL-7, MCP-1, CCL5, Eotaxin-2) but IL-1α and TNFβ increased. Fecal 16s rRNA analyses revealed no GFD-driven differences in alpha or beta diversity, but at genus level, post-GFD samples had lower abundances of Roseburia, Faecalibacterium, and Bifidobacterium and higher abundances of Bacteroides. In sum, removal of gluten reduced several markers of systemic inflammation, independent of HLA-DR3/DR4, suggesting gluten may potentiate innate inflammation and T1D progression in those with underlying susceptibility. This may occur by altering gut barrier integrity and/or shifts in microbial taxa/metabolites. These data suggest mechanisms by which gluten may directly and indirectly drive T1D progression. Presentation: Thursday, June 15, 2023

Electrode Erosion Phenomena in a High-Energy Pulsed Discharge

Temporal development of the gut microbiome in early childhood from the TEDDY study

Looking back at the TEDDY study: lessons and future directions

Changes to the Gut Microbiome in Young Children Showing Early Behavioral Signs of Autism

THU274 Gluten Free Diet Reduces Systemic Innate Inflammation in Children Genetically Susceptible To Type 1 Diabetes

High-throughput liquid-liquid fractionation of multiple protein post-translational modifications.

Delayed gut microbiota maturation in the first year of life is a hallmark of pediatric allergic disease

Composition and Associations of the Infant Gut Fungal Microbiota with Environmental Factors and Childhood Allergic Outcomes

Variations among untreated rabbits in benzo(a)pyrene metabolism and its modulation by 7,8-benzoflavone.

Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age.

Gut microbiota trajectory in early life may predict development of celiac disease

The protective effect of the intestinal microbiota in type-1 diabetes in NOD mice is limited to a time window in early life

Dynamics of the gut microbiome, IgA response, and plasma metabolome in the development of pediatric celiac disease

Early infancy microbial and metabolic alterations affect risk of childhood asthma

Early-life exposures to specific commensal microbes prevent type 1 diabetes

Prospective virome analyses in young children at increased genetic risk for type 1 diabetes

Reply To: Sleep Disturbances in Childhood Cancer Survivors

Analysis of Gut Bacterial and Fungal Microbiota in Children with Autism Spectrum Disorder and Their Non-Autistic Siblings

Lymphocyte culture from routine endomyocardial biopsies: lack of clinical or pathological correlations.

Children Who Develop Celiac Disease Exhibit Distinct Metabolic Pathways Among Their Gut Microbiota Years Before Diagnosis

The intestinal microbiome of inflammatory bowel disease across the pediatric age range